KRAS and colorectal carcinoma: Radiotherapy resistance of CRC with KRAS mutations was realised by rapid upregulation of heterogeneous nuclear ribonucleoprotein KhnRNP K, and MEK inhibition effectively increased radiotherapy sensitivity of CRC168.